2010
DOI: 10.1002/ana.22089
|View full text |Cite
|
Sign up to set email alerts
|

A phase I trial of deep brain stimulation of memory circuits in Alzheimer's disease

Abstract: There is an urgent need for novel therapeutic approaches for AD. Modulating pathological brain activity in this illness with DBS merits further investigation.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

8
595
0
9

Year Published

2011
2011
2016
2016

Publication Types

Select...
9
1

Relationship

1
9

Authors

Journals

citations
Cited by 713 publications
(623 citation statements)
references
References 66 publications
8
595
0
9
Order By: Relevance
“…Several recent papers also documented that sLORETA reveals valid results (e.g. Betting et al, 2010;Dümpelmann et al, in press;Laxton et al, 2010). Particularly noteworthy is a comparative validation study using intracranial recordings from epilepsy patients (Plummer et al, 2010) where they show that overall, sLORETA is the method with lowest localization error.…”
Section: Data Conditioningmentioning
confidence: 84%
“…Several recent papers also documented that sLORETA reveals valid results (e.g. Betting et al, 2010;Dümpelmann et al, in press;Laxton et al, 2010). Particularly noteworthy is a comparative validation study using intracranial recordings from epilepsy patients (Plummer et al, 2010) where they show that overall, sLORETA is the method with lowest localization error.…”
Section: Data Conditioningmentioning
confidence: 84%
“…First, mechanisms underlying the pro-cognitive effects of DBS likely include, but need not be limited to, activity-dependent promotion of adult neurogenesis. For example, stimulation may induce neurotransmitter release and local or transsynaptic modulation of neural activity at the cellular level (Kringelbach et al, 2007), as well as restore basal activity levels within dysregulated brain regions at the circuit level (Mayberg et al, 2005;Laxton et al, 2010). Such effects might act in concert with stimulation-induced changes in neurogenesis to promote cognitive recovery.…”
Section: Discussionmentioning
confidence: 99%
“…On the other hand, neurodegenerative diseases, such as Alzheimer's or other forms of dementia, appear to have increased in frequency over the past decade. The deep brain electrical stimulation of the Alzheimer's disease patients using implantable metal electrodes showed improvements and/or slowed the rate of cognitive decline at 6 and 12 months in some patients without any adverse side effects 3 . Stroke and epilepsy leave many people disabled for life.…”
Section: Graphical Abstract 1 Introductionmentioning
confidence: 96%